Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention

International Journal of Drug Policy

Volumn 19, Issue 1, 2008, Pages 17-23

  Bruce, R Douglas ^a   Schleifer, Rebecca A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Buprenorphine; Human rights; Incarceration; Medication assisted treatment; Methadone; Opioid substitution therapy; Prison

Indexed keywords

BUPRENORPHINE; METHADONE; OPIATE;

ARTICLE; BEHAVIOR DISORDER; DRUG DEPENDENCE; DRUG WITHDRAWAL; ETHICS; HEALTH CARE ORGANIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; PRIORITY JOURNAL; PRISON; RISK FACTOR; WITHDRAWAL SYNDROME; WORLD HEALTH ORGANIZATION;

EID: 39049137365     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.11.019     Document Type: Note

References (74)

1. Beck A., Gillard D., Greenfeld L., Harlow C., Hester T., Jankowski L., et al. Survey of state prison inmates, 1991 (1993), US Department of Justice, Bureau of Justice Statistics, Washington, DC
2. Belenko S., Peugh J., Usdansky M., Kurzweil B., Liu H., and Foster S. Behind bars: Substance abuse and America's prison population (1998), National Center on Addiction and Substance Abuse, New York
3. Beyrer C., Jittiwutikarn J., Teokul W., Razak M.H., Suriyanon V., Srirak N., et al. Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS & Behavior 7 2 (2003) 153-164
4. Boys A., Farrell P., Bebbington P., Brugha T., Coid J., Jenkins R., et al. Drug use and initiation in prison: Results from a national prison survey in England in Wales. Addiction 97 (2002) 1551-1560
5. Calzavara L.M., Burchell A.N., Schlossberg J., Myers T., Escobar M., Wallace E., et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction 98 9 (2003) 1257-1265
6. Catania H. Substitution treatment in prison: Evaluating a pilot, expanding an intervention. 15th international conference on the reduction of drug related harm. Melbourne, Australia (2004)
7. Chao J., and Nestler E.J. Molecular neurobiology of drug addiction. Annual Review of Medicine 55 (2004) 113-132
8. Choopanya K., Des Jarlais D.C., Vanichseni S., Kitayaporn D., Mock P.A., Raktham S., et al. Incarceration and risk for HIV infection among injection drug users in Bangkok. Journal of Acquired Immune Deficiency Syndrome 29 1 (2002) 86-94
9. Committee Against Torture (CAT). (1984). Convention against torture and other cruel, inhuman or degrading treatment or punishment. Adopted December 10, 1984, G.A. res. 39/46, annex, 39 U.N. GAOR Supp. (no. 51) at 197, U.N. Doc. A/39/51 (1984), entered into force June 26, 1987, articles 1, 2.
10. Committee on Economic, Social and Cultural Rights (CESCR). (1994). General Comment No. 5, persons with disabilities. Eleventh session, U.N. Doc. E/1995/22 at 19, reprinted in Compilation of general comments and general recommendations, adopted by Human Rights Treaty Bodies, U.N. Doc. HRI/GEN/1/Rev.6 at 24 (2003).
11. Committee on Economic Social and Cultural Rights (CESCR). (2000). General Comment No. 14. E/C.12/2000/4, article 2(2), paragraphs 16, 18, 30-37. URL: http://www.unhchr.ch/tbs/doc.nsf/(symbol)/E.C.12.2000.4.En.
12. Cravioto P., Medina-Mora M.E., de la Rosa B., Galvan F., and Tapia-Conyer R. Patterns of heroin consumption in a jail on the northern Mexican border: Barriers to treatment access. Salud Publica de Mexico 45 (2003) 181-190
13. Cysique L.A., Maruff P., and Brew B.J. The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: A meta-analysis. Journal of the International Neuropsychological Society 12 3 (2006) 368-382
14. Di Chiara G., and North R.A. Neurobiology of opiate abuse. Trends in Pharmacological Sciences 13 5 (1992) 185-193
15. Dolan K., Hall W., and Wodak A. Methadone maintenance reduces injecting in prison. British Medical Journal 312 7039 (May 4 1996) 1162
16. Dolan K., Kite B., Black E., Aceijas C., and Stimson G.V. HIV in prison in low-income and middle-income countries. The Lancet Infectious Diseases 7 1 (2006) 32-41
17. Dolan K., Wodak A., and Hall W. Methadone maintenance treatment reduces heroin injection in new South Wales prison. Drug Alcohol Review 17 (1998) 153-158
18. Dole V.P. Detoxification of sick addicts in prison. JAMA 220 (1972) 366-369
19. European Committee for the Prevention of Torture and Inhuman or Degrading Treatment or Punishment (CPT). (2002). CPT standards. CPT/IN/E (2002), section 3.
20. European Convention for the Protection of Human Rights and Fundamental Freedoms (ECPHRFF). (1953). 213 UNTS. 222, entered into force September 3, 1953, as amended by protocol nos. 3, 5, 8, and 11 which entered into force on September 21, 1970, December 20, 1971, January 1, 1990, and November 1, 1998, respectively, article 3.
21. European Court of Human Rights (ECHR). (2003). Pantea v. Romania. Application no. 33343/96 (judgment of June 3, 2003).
22. European Court of Human Rights (ECHR). (2006). Melnik v. Ukraine. Application no. 72286/01 (judgment of March 28, 2006).
23. Fallon B.M. The key extended entry program (KEEP): From the community side of the bridge. Mount Sinai Journal of Medicine 68 (2001) 21-27
24. Farrell M., Boys A., Singleton N., Meltzer H., Brugha T., Bebbington P., et al. Predictors of mental health service utilization in the 12 months before imprisonment: Analysis of results from a national prisons survey. Australian & New Zealand Journal of Psychiatry 40 6-7 (2006) 548-553
25. Fiellin D.A., and O'Connor P.G. New federal initiatives to enhance the medical treatment of opioid dependence. Annals of Internal Medicine 137 8 (2002) 688-692
26. Fiscella K., Moore A., Engerman J., and Meldrum S. Management of opiate detoxification in jails. Journal of Addictive Diseases 24 (2005) 61-71
27. Forton D.M., Allsop J.M., Cox I.J., Hamilton G., Wesnes K., Thomas H.C., et al. A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS 19 Suppl. 3 (2005) S53-S63
28. Gore S.M., and Bird A.G. Mandatory drug tests in prisons. British Medical Journal 310 6979 (1995) 595
29. Haig T. Randomized controlled trial proves effectiveness of MMT in prison. Canadian HIV/AIDS Law and Policy Review 8 (2003) 48
30. Heimer R., Catania H., Newman R.G., Zambrano J., Brunet A., and Ortiz A.M. Methadone maintenance in prison: Evaluation of a pilot program in Puerto Rico. Drug and Alcohol Dependence 83 2 (2006) 122
31. Heimer R., Zambrano J.A., Brunet A., Ortiz A.M., Catania H., and Newman R.G. Methadone maintenance in a men's prison in Puerto Rico: A pilot program. Journal of Correctional Health Care 11 3 (2005) 295-305
32. Human Rights Watch. (2007). Russian Federation-rehabilitation required: The right to drug dependence treatment in the Russian Federation. November 2007.
33. International Council of Prison Medical Services. (1979). The oath of Athens. Available at: http://www.prisonhealthcarepractitioners.com/Medical_ethics.shtml#International_Council_of_Prison_Medical_Services.
34. International Covenant on Civil and Political Rights (ICCPR). (1966). Adopted December 16, 1966, G.A. Res. 2200A (XXI), 21 U.N. GAOR Supp. (no. 16) at 52, U.N. Doc. A/6316 (1966), 999 U.N.T.S. 171, entered into force March 23, 1976, article 7.
35. Kaufman M.J., Pollack M.H., Villafuerte R.A., Kukes T.J., Rose S.L., and Mendelson J.H. Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance. Psychiatry Research 90 3 (1999) 143-152
36. Kerr T., and Jurgens R. Methadone maintenance therapy in prisons: Reviewing the evidence (2004), Canadian HIV/AIDS Legal Network, Montreal, Canada
37. Kresina T.F., Bruce R.D., Litwin A.H., and Sylvestre D. Hepatitis C treatment of substance users in pharmacotherapy for addiction. Current Hepatitis Reports 4 3 (2005) 112-119
38. Laskus T., Radkowski M., Adair D.M., Wilkinson J., Scheck A.C., and Rakela J. Emerging evidence of hepatitis C virus neuroinvasion. AIDS 19 Suppl. 3 (2005) S140-S144
39. Lines R. From equivalence of standards to equivalence of objectives: The entitlement of prisoners to health standards higher than those outside prisons. International Journal of Prisoner Health 2 4 (2006) 269
40. Mumola C., and Beck A.J. Bureau of Justice Statistics bulletin (1997), US Department of Justice, Office of Justice Programs, Washington, DC
41. Nestler E.J. Molecular neurobiology of addiction. American Journal on Addictions 10 3 (2001) 201-217
42. Nestler E.J. Psychogenomics: Opportunities for understanding addiction. Journal of Neuroscience 21 21 (2001) 8324-8327
43. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 Suppl. 1 (2004) 24-32
44. Nestler E.J., and Aghajanian G.K. Molecular and cellular basis of addiction. Science 278 5335 (1997) 58-63
45. Nestler E.J., Alreja M., and Aghajanian G.K. Molecular and cellular mechanisms of opiate action: Studies in the rat locus coeruleus. Brain Research Bulletin 35 5-6 (1994) 521-528
46. Nestler E.J., Berhow M.T., and Brodkin E.S. Molecular mechanisms of drug addiction: Adaptations in signal transduction pathways. Molecular Psychiatry 1 3 (1996) 190-199
47. Nestler E.J., Hopem B.T., and Widnell K.L. Drug addiction: A model for the molecular basis of neural plasticity. Neuron 11 6 (1993) 995-1006
48. Parsons T.D., Tucker K.A., Hall C.D., Robertson W.T., Eron J.J., Fried M.W., et al. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. AIDS 20 12 (2006) 1591-1595
49. Rollins A.L., O'Neill S.J., Davis K.E., and Devitt T.S. Substance abuse relapse and factors associated with relapse in an inner-city sample of patients with dual diagnoses. Psychiatric Services 56 10 (2005) 1274-1281
50. Sefatian S., Alaei K., and Alaei A. The harm reduction policy to help drug users in Iran. Proceedings of the 16th international conference on the reduction of drug-related harm. Belfast, UK (2005)
51. Shaham Y., Erb S., and Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: A review. Brain Research: Brain Research Reviews 33 1 (2000) 13-33
52. Shewan D., Gemmell M., and Davies J.B. Behavioural change amongst injecting drug users in Scottish prisons. Social Science and Medicine 39 11 (1994) 1585-1586
53. Sibbald B. Methadone maintenance expands inside federal prisons. Canadian Medical Association Journal 167 (2002) 1154
54. Small W., Kain S., Laliberte N., Schechter M.T., O'Shaughnessy M.V., and Spittal P.M. Incarceration, addiction and harm reduction: Inmates experience injecting drugs in prison. Substance Use & Misuse 40 6 (2005) 831-843
55. Stimmel B., and Kreek M.J. Neurobiology of addictive behaviors and its relationship to methadone maintenance. Mount Sinai Journal of Medicine 67 5-6 (2000) 375-380
56. The Hemophilia Growth Development Study. Hepatitis C virus infection and neurocognitive function. Neurology 67 8 (2006) 1482-1485
57. Tomasino V., Swanson A.J., Nolan J., and Shuman H.I. The key extended entry program (KEEP): A methadone treatment program for opiate-dependent inmates. Mount Sinai Journal of Medicine 68 (2001) 14-20
58. United Nations General Assembly (UNGA). (1982). Principles of medical ethics relevant to the role of health personnel, particularly physicians, in the protection of prisoners and detainees against torture and other cruel, inhuman or degrading treatment or punishment. General Assembly Resolution 37/194, annex, 37 U.N. GAOR Supp. (no. 51) at 211, U.N. Doc. A/37/51.
59. United Nations General Assembly (UNGA). (1988). Body of principles for the protection of all persons under any form of detention or imprisonment. UN General Assembly resolution 43/173, principle 7.
60. United Nations General Assembly (UNGA). (2001). Report of the special rapporteur on the question of torture and other cruel, inhuman or degrading treatment or punishment. U.N. Doc. A/56/156, section IIA.
61. United Nations Human Rights Committee (UNHRC). (1992a). General Comment 20. Article 7 (forty-fourth session, 1992). Compilation of general comments and general recommendations adopted by Human Rights Treaty Bodies, U.N. Doc. HRI/GEN/1/Rev.1 at 30, paragraph 5.
62. United Nations Human Rights Committee (UNHRC). (1992b). General Comment 21 (forty-fourth session, 1992). Compilation of general comments and general recommendations adopted by Human Rights Treaty Bodies, U.N. Doc. HRI/GEN/1/Rev.1 at 33, paragraph 3.
63. United Nations Human Rights Committee (UNHRC). (1994). General Comment No. 21. Article 10. Humane treatment of prisoners deprived of their liberty. UN Doc. HRI/Gen/1/Rev.1 at 33, paragraph 3.
64. United Nations Human Rights Committee (UNHRC). (2002). Lantsova v. Russian Federation. 763/1997, UNCHR 74th session (2002), UN Doc. Ccpr/C/74/763/1997, paragraph 9.2.
65. United Nations Office on Drugs and Crime (UNODC). (2006). HIV/AIDS prevention, care, treatment and support in prison settings. A framework for an effective national response. New York: United Nations.
66. U.S. Department of Health and Human Services (USDHHS). (2005). Medication-assisted treatment for opioid addiction in opioid treatment programs. Treatment improvement protocol (TIP) series 43. Substance Abuse and Mental Health Services Administration/Center for Substance Abuse Treatment, DHHS publication no. (SMA) 05-4048. Rockville, MD: Substance Abuse and Mental Health Services Administration.
67. van Haastrecht H.J., Bax J.S., and van den Hoek A.A. High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons. Addiction 93 9 (1998) 1417-1425
68. Volkow N., and Li T.K. The neuroscience of addiction. Nature Neuroscience 8 11 (2005) 1429-1430
69. Vormfelde S.V., and Poser W. Death attributed to methadone. Pharmacopsychiatry 34 6 (Nov 2001) 217-222
70. Waldrop-Valverde D., Ownby R.L., Wilkie F.L., Mack A., Kumar M., and Metsch L. Neurocognitive aspects of medication adherence in HIV-positive injecting drug users. AIDS & Behavior 10 3 (2006) 287-297
71. Wood E., Montaner J., and Kerr T. HIV risks in incarcerated injection-drug users. Lancet 366 9500 (2005) 1834-1835
72. Wood, E., et al. (2005). Recent incarceration independently associated with syringe sharing by injection drug users. Public health reports, vol. 120. March-April 2005, pp. 150-156.
73. World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC) and Joint United Nations Programme on HIV/AIDS (UNAIDS). (2004). Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: Position paper. URL: www.who.int/substance_abuse/publications/en/PositionPaper_English.pdf.
74. Zule W.A., and Desmond D.P. Attitudes toward methadone maintenance: Implications for HIV prevention. Journal of Psychoactive Drugs 30 January-February (1) (1998) 89-97